NCT04067310View on ClinicalTrials.gov

Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 16, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

January 20, 2023

Conditions
RadiodermatitisInjury, Radiation
Interventions
OTHER

Spray skin protector

Patients will use spray skin protector treatment from the randomization day until the last day of radiotherapy.

OTHER

moisturizer Dnativ Revita derm

Patients will use conventional preventive treatment from the randomization day until the last day of radiotherapy.

Trial Locations (1)

20231092

INCA Research Center, Rio de Janeiro

All Listed Sponsors
collaborator

Rio de Janeiro State Research Supporting Foundation (FAPERJ)

OTHER_GOV

lead

Instituto Nacional de Cancer, Brazil

OTHER_GOV

NCT04067310 - Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis. | Biotech Hunter | Biotech Hunter